英文名稱 |
中文名稱 |
CAS號 |
操作 |
Methyl 5,6-dibromo-1H-indole-3-carboxylate |
5,6-Dibromo-1H-indole-3-carboxylic acid methyl ester |
1309792-72-0 |
詳細(xì)
|
VU0360172 |
化合物 T29126 |
1310012-12-4 |
詳細(xì)
|
LXW7 |
LXW7 |
1313004-77-1 |
詳細(xì)
|
VUT-MK142 |
化合物VUT-MK142 |
1313491-22-3 |
詳細(xì)
|
6-[(3S,8S,9S,10R,13S,14S,17S)-3-hydroxy-10,13-dimethyl-2,3,4,7,8,9,11,12,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-17-yl]-2-oxo-1H-pyridine-3,4-dicarbonitrile |
化合物T64393 |
1314134-92-3 |
詳細(xì)
|
MSDC-0602K |
MSDC-0602K |
1314533-27-1 |
詳細(xì)
|
3-hydroxy-3-phenylpentanamide |
3-hydroxy-3-phenylpentamide |
131802-69-2 |
詳細(xì)
|
UNC1021 |
化合物UNC?1021 |
1322591-19-4 |
詳細(xì)
|
SI 60 |
(4-羥基苯基)(甲基)(萘-1-基甲基)锍六氟銻酸鹽 |
133152-67-7 |
詳細(xì)
|
Modoflaner |
化合物MODOFLANER |
1331922-53-2 |
詳細(xì)
|
ND-322 HCl |
化合物 T28145 |
1333379-23-9 |
詳細(xì)
|
WWL 154 |
4-硝基苯基 4-(4-甲氧基苯基)哌嗪-1-甲酸酯 |
1338574-93-8 |
詳細(xì)
|
NCGC00229600 |
4(1H)-Quinazolinone, 2-[3-[(2,6-diMethylphenoxy)Methyl]-4-Methoxyphenyl]-2,3-dihydro-3-(3-pyridinylMethyl)- |
1338824-20-6 |
詳細(xì)
|
Triplin |
化合物 T34956 |
1421584-86-2 |
詳細(xì)
|
BRD 9757 |
BRD 9757 |
1423058-85-8 |
詳細(xì)
|
(Z)-4-(5-((5-(4-bromophenyl)furan-2-yl)methylene)-4-oxo-2-thioxothiazolidin-3-yl)butanoic acid |
化合物 ASK1-IN-4 |
1427538-26-8 |
詳細(xì)
|
Teplinovivint |
化合物TEPLINOVIVINT |
1428064-91-8 |
詳細(xì)
|
JNJ-42253432 |
化合物 T27683 |
1428327-35-8 |
詳細(xì)
|
MM41 |
化合物 MM41 |
1429028-96-5 |
詳細(xì)
|
AKT-IN-6 |
INCB-047775 |
1430056-54-4 |
詳細(xì)
|
(25R)-3β,17α-dihydroxy-5α- spirostan-6-one3-O-α-L- rhamnopyranosyl-(1→2)-β- D-glucopyranoside |
Spirostan-6-one, 3-[[2-O-(6-deoxy-α-L-mannopyranosyl)-β-D-glucopyranosyl]oxy]-17-hydroxy-, (3β,5α,25R)- |
143051-94-9 |
詳細(xì)
|
SIRT-IN-1 |
SIRT-IN-1 |
1431411-60-7 |
詳細(xì)
|
SIRT-IN-2 |
4-[4-[2-[(METHYLSULFONYL)AMINO]ETHYL]-1-PIPERIDINYL]-THIENO[3,2-D]PYRIMIDINE-6-CARBOXAMIDE |
1431411-66-3 |
詳細(xì)
|
FATP1-IN-1 |
化合物FATP1-IN-1 |
1431945-95-7 |
詳細(xì)
|
VU0453595 |
VU0453595 |
1432436-13-9 |
詳細(xì)
|
Eltoprazine dihydrochloride |
依托拉嗪二鹽酸鹽 |
143485-51-2 |
詳細(xì)
|
WCK-5153 |
WCK-5153 |
1436862-38-2 |
詳細(xì)
|
Heteroclitin G |
1H-Indeno[7'a,1':1,2]indeno[5,6-d][1,3]dioxol-1-one, 5,6,6a,7-tetrahydro-7-hydroxy-2,3,12-trimethoxy-6,6a-dimethyl-, (6R,6aR,7S,12bS)- |
144027-74-7 |
詳細(xì)
|
sodium 3-amino-4,6-dimethylthieno[2,3-b]pyridine-2-carboxylate |
SODIUM 3-AMINO-4,6-DIMETHYLTHIENO[2,3-B]PYRIDINE-2-CARBOXYLATE |
144254-93-3 |
詳細(xì)
|
Binodenoson |
比諾地松 |
144348-08-3 |
詳細(xì)
|
5-MethoxyPinocembroside |
5-MethoxyPinocembroside |
1450878-89-3 |
詳細(xì)
|
Nacubactam |
OP-0595 |
1452458-86-4 |
詳細(xì)
|
Elevenostat |
N-羥基-4-((3-(2-甲氧基苯基)脲基)甲基)苯甲酰胺 |
1454902-97-6 |
詳細(xì)
|
MSC2504877 |
化合物MSC2504877 |
1460286-21-8 |
詳細(xì)
|
Olanexidine hydrochloride |
Olanexidine hydrochloride |
146509-94-6 |
詳細(xì)
|
Thymosin β4 acetate(75591-33-4 free base) |
胸腺素 BETA 4 |
1346423-89-9 |
詳細(xì)
|
CP-289 |
化合物CP-289 |
1349637-14-4 |
詳細(xì)
|
ZX-J-19J |
化合物ZX-J-19J |
1352576-02-3 |
詳細(xì)
|
TL-895 |
2-Propen-1-one, 1-[4-[[[6-amino-5-(4-phenoxyphenyl)-4-pyrimidinyl]amino]methyl]-4-fluoro-1-piperidinyl]- |
1415823-49-2 |
詳細(xì)
|
RO-5963 |
RO-5963 |
1416663-77-8 |
詳細(xì)
|
(2S)-4-biphenyl-4-yl-N-hydroxy-2-methyl-2-(methylsulfonyl)butanamide |
化合物T60205 |
1354546-42-1 |
詳細(xì)
|
T-3364366 |
T-3364366 |
1356354-09-0 |
詳細(xì)
|
CYP11B2-IN-1 |
CYP11B2-IN-1 |
1356479-78-1 |
詳細(xì)
|
N-Me-aminopyrimidinone9 |
N-Me-aminopyrimidinone 9 |
1356834-62-2 |
詳細(xì)
|
FEMA 4774 |
化合物FEMA 4774 |
1359963-68-0 |
詳細(xì)
|
Wnt pathway activator 2 |
Wnt pathway activator 2 |
1360540-82-4 |
詳細(xì)
|
MOMIPP |
艾司西酞普蘭雜質(zhì) |
1363421-46-8 |
詳細(xì)
|
3,3'-Bi[1H-indole] |
MFCD01321109 |
13637-37-1 |
詳細(xì)
|
Parethoxycaine hydrochloride |
對乙氧卡因 |
136-46-9 |
詳細(xì)
|
DHODH-IN-13 |
DHODH-IN-13 |
1364791-86-5 |
詳細(xì)
|
DHODH-IN-15 |
DHODH-IN-15 |
1364791-88-7 |
詳細(xì)
|
DHODH-IN-14 |
DHODH-IN-14 |
1364791-93-4 |
詳細(xì)
|
LP-922056 |
LX5061 |
1365060-22-5 |
詳細(xì)
|
5-(2-aminoethyl)-4-methyl-1,3-thiazol-2-amine dihydrochloride |
5-(2-aminoethyl)-4-methyl-1,3-thiazol-2-amine dihydrochloride |
136604-58-5 |
詳細(xì)
|
Minimolide F |
Minimolide F |
1367351-41-4 |
詳細(xì)
|
EML4-ALK kinase inhibitor 1 |
EML4-ALK kinase inhibitor 1 |
1373409-08-5 |
詳細(xì)
|
YH-306 |
化合物 T24642 |
1373764-75-0 |
詳細(xì)
|
FEMA-4809 |
化合物 T27308 |
1374760-95-8 |
詳細(xì)
|
LY2880070 |
LY2880070 |
1375637-35-6 |
詳細(xì)
|
1-(cyclohexylmethyl)guanidine hydroiodide |
N-(cyclohexylmethyl)guanidine hydroiodide |
1376324-09-2 |
詳細(xì)
|
Fosciclopirox |
Fosciclopirox |
1380539-06-9 |
詳細(xì)
|
MK-8719 |
(3AR,5S,6S,7R,7AR,E)-5-(二氟甲基)-2-(乙基亞氨基)六氫-5H-吡喃[3,2-D]噻唑-6,7-二醇 |
1382799-40-7 |
詳細(xì)
|
N-[2-(5-Chloro-1H-indol-3-yl)ethyl]-4'-cyanobiphenyl-2-carboxaMide |
化合物T60041 |
1383373-65-6 |
詳細(xì)
|
Cefalonium Dihydrate(5575-21-3 free base) |
CEPHALONIUM DIHYDRATE STANDARD |
1385046-35-4 |
詳細(xì)
|
Umibecestat |
Umibecestat |
1387560-01-1 |
詳細(xì)
|
Darapladib-impurity |
達(dá)雷拉地雜質(zhì) |
1389264-17-8 |
詳細(xì)
|
MAT2A inhibitor 4 |
化合物T9262 |
1391934-91-0 |
詳細(xì)
|
Cy3 NHS ester |
CYANINE3 NHS ESTER |
1393363-07-9 |
詳細(xì)
|
Ro24-7429 |
7-氯-N-甲基-5-(1H-吡咯-2-基)-3H-1,4-苯并二氮雜卓-2-胺 |
139339-45-0 |
詳細(xì)
|
2-CHLOROMETHYL-1,1-DIOXO-1,2-DIHYDRO-1LAMBDA*6*-BENZO[D]ISOTHIAZOL-3-ONE |
2-(氯甲基)-2,3-二氫1Λ,2苯并噻-1,1,3-三酮 |
13947-21-2 |
詳細(xì)
|
Samelisant |
SUVN-G3031 |
1394808-82-2 |
詳細(xì)
|
RIP2 Kinase Inhibitor 3 |
RIP2 Kinase Inhibitor 3 |
1398053-50-3 |
詳細(xì)
|
Cdc7-IN-5 |
Cdc7-IN-5 |
1402057-86-6 |
詳細(xì)
|
AS-0141 |
Cdc7-IN-6 |
1402057-88-8 |
詳細(xì)
|
Cdc7-IN-7 |
Cdc7-IN-7 |
1402059-17-9 |
詳細(xì)
|
hSMG-1 inhibitor 11e |
化合物T35529 |
1402452-10-1 |
詳細(xì)
|
DAGLβ-IN-1 |
CarbaMic acid, N-[5-[(2-phenylethyl)[[4-[4-(trifluoroMethoxy)phenyl]-1H-1,2,3-triazol-1-yl]carbonyl]aMino]pentyl]-, 1,1-diMethylethyl ester |
1402612-61-6 |
詳細(xì)
|
Runcaciguat |
RUNCACIGUAT |
1402936-61-1 |
詳細(xì)
|
Vibozilimod |
VIBOZILIMOD |
1403232-33-6 |
詳細(xì)
|
(S)-2-((R)-3-(4-chlorophenyl)-N’-((4-chlorophenyl)sulfonyl)-4-phenyl-4,5-dihydro-1H-pyrazole-1-carboximidamido)-3-methylbutanamide |
化合物T9281 |
1404117-65-2 |
詳細(xì)
|
Gnetifolin E |
Gnetifolin E |
140671-07-4 |
詳細(xì)
|
Fuzapladib |
夫扎拉迪鈉 |
141283-87-6 |
詳細(xì)
|
Enavogliflozin |
D-Glucitol, 1,5-anhydro-1-C-[7-chloro-6-[(4-cyclopropylphenyl)methyl]-2,3-dihydro-4-benzofuranyl]-, (1S)- |
1415472-28-4 |
詳細(xì)
|
WAY-272077 |
化合物WAY-272077 |
1415662-57-5 |
詳細(xì)
|
ARRY 520 hydrochloride |
(2S)-2-(3-Aminopropyl)-5-(2,5-difluorophenyl)-N-methoxy-N-methyl-2-phenyl-1,3,4-thiadiazole-3(2H)-carboxamide Hydrochloride |
1385020-40-5 |
詳細(xì)
|
(+)-6-(2-Hydroxy-3-methoxy-3-methylbutyl |
化合物TN7021L |
137182-35-5 |
詳細(xì)
|
N-((4-([1,2,4]triazolo[1,5-a]pyridin-6-yl)-5-(6-methylpyridin-2-yl)-1H-imidazol-2-yl)methyl)-2-bromoaniline |
化合物T9837 |
1352608-94-6 |
詳細(xì)
|
TFMB-(S)-2-HG |
[3-(Trifluoromethyl)phenyl]methyl (2S)-5-oxooxolane-2-carboxylate |
1445703-64-9 |
詳細(xì)
|
Opiranserin hydrochloride |
OPIRANSERIN鹽酸鹽 |
1440796-75-7 |
詳細(xì)
|
Merodantoin |
化合物 T33296 |
143413-73-4 |
詳細(xì)
|
WDR5-47 |
2-氯-4-氟-3-甲基-N-(2-(4-甲基哌嗪-1-基)-5-硝基苯基)苯甲酰胺 |
1422389-91-0 |
詳細(xì)
|
Ellagic acid 3-O-α-L-rhamnopyranoside |
鞣花酸3-O-Α-L-鼠李糖苷 |
1422265-57-3 |
詳細(xì)
|
Dynamin IN-2 |
化合物 DYNAMIN IN-2 |
1345853-49-7 |
詳細(xì)
|
3-(2-phenylethynyl)pyridine |
3-PHENYLETHYNYL-PYRIDINE |
13238-38-5 |
詳細(xì)
|
hGPR91 antagonist 1 |
(S)-2-(4-(1,8-萘啶-2-基)苯基)-N-(1-(4'-氟-3'-(三氟甲基)-[1,1'-聯(lián)苯]-4-基)乙基)乙酰胺 |
1314796-00-3 |
詳細(xì)
|
MCI-225 |
4-(2-FLUOROPHENYL)-6-METHYL-2-(1-PIPERAZINYL)THIENO[2,3-D]PYRIMIDINE |
135991-48-9 |
詳細(xì)
|
VPC-70063 |
化合物VPC-70063 |
13571-44-3 |
詳細(xì)
|
β-Aminoarteether |
Β-AMINOARTEETHER |
133162-24-0 |
詳細(xì)
|
IPI-9119 |
IPI-9119 |
1346564-56-4 |
詳細(xì)
|
K-8012 |
化合物 T24240 |
1346513-17-4 |
詳細(xì)
|